McLaren Central Michigan
Mount Pleasant, Michigan, United States
Hospital in Mount Pleasant, Michigan
1221 South Dr, Mt Pleasant, MI 48858
About McLaren Central Michigan
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Michigan State University
1
Radiation Therapy Oncology Group
1
SWOG Cancer Research Network
1
Clinical Trials at McLaren Central Michigan
During the past decade, McLaren Central Michigan conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
2009-09-01
2025-10-01
Active, not recruiting
1,538
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
2009-07-15
2022-02-08
Completed
1,333
Saw Palmetto: Symptom Management for Men During Radiation Therapy
2011-10-01
2015-04-01
Completed
48
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "McLaren Central Michigan"
#1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at McLaren Central Michigan
According to Clinical.Site data, the most researched conditions in "McLaren Central Michigan" are
"Prostate Cancer" (2 trials), "Recurrent Large Cell Lung Carcinoma" (1 trials), "Recurrent Lung Adenocarcinoma" (1 trials), "Recurrent Squamous Cell Lung Carcinoma" (1 trials) and "Stage IV Large Cell Lung Carcinoma" (1 trials). Many other conditions were trialed in "McLaren Central Michigan" in a lesser frequency.
Clinical Trials Intervention Types at McLaren Central Michigan
Most popular intervention types in "McLaren Central Michigan" are "Drug" (3 trials), "Biological" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (1 trials), "Carboplatin" (1 trials), "Cetuximab" (1 trials), "Dose-Escalated Radiation Therapy" (1 trials) and "LHRH agonist (antagonist) therapy" (1 trials). Other intervention names were less common.
Clinical Trials Genders at McLaren Central Michigan
The vast majority of trials in "McLaren Central Michigan" are
2 trials for "Male" genders and 1 trials for "All" genders.
Clinical Trials Status at McLaren Central Michigan
Currently, there are NaN active trials in "McLaren Central Michigan".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in McLaren Central Michigan,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in McLaren Central Michigan, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".